Breaking News Instant updates and real-time market news.

DBD

Diebold

$22.35

-0.2 (-0.89%)

, NCR

NCR Corp.

$36.60

0.05 (0.14%)

05:35
08/08/17
08/08
05:35
08/08/17
05:35

Diebold downgraded to Neutral from Overweight at JPMorgan

JPMorgan analyst Paul Coster downgraded Diebold (DBN) to Neutral citing a lack of near-term catalysts and valuation following the company's Q2 results. The analyst prefers Overweight-rated peer NCR Corp. (NCR) at current trading multiples. He has a $31 price target for Diebold shares.

DBD

Diebold

$22.35

-0.2 (-0.89%)

NCR

NCR Corp.

$36.60

0.05 (0.14%)

  • 08

    Aug

  • 10

    Aug

DBD Diebold
$22.35

-0.2 (-0.89%)

06/19/17
LSCM
06/19/17
INITIATION
Target $38
LSCM
Buy
Diebold initiated with a Buy at Lake Street
Lake Street analyst Josh Elving started Diebold with a Buy rating and $38 price target. The shares offer one of the best return opportunities in the FinTech space over the next few years, the analyst contends. He views Diebold's story as "misunderstood and underfollowed today."
07/05/17
JPMS
07/05/17
NO CHANGE
JPMS
Overweight
NCR should be bought on today's weakness, says JPMorgan
JPMorgan analyst Paul Coster recommends using the weakness in shares of NCR Corp. (NCR) following Diebold's (DBD) preannouncement as a buying opportunity. After touching base with NCR, the analyst thinks the issues at Diebold are company specific and that NCR remains on track to meet expectations. While more cautious Diebold's near-term prospects, Coster believes today's 20% selloff "seems excessive." He thinks the company's execution issues probably get resolved by year-end. The analyst keeps Overweight ratings on both stocks.
07/10/17
JPMS
07/10/17
NO CHANGE
JPMS
JPMorgan says buy NCR and Diebold on recent pullback
JPMorgan analyst Paul Coster recommends buying both NCR Corp. (NCR) and Diebold (DBD) on the recent weakness caused by Diebold's negative preannouncement last week. After speaking to both managements, the analyst concludes that the companies are experiencing "largely uninterrupted" demand for ATMs, retail self-checkout terminals and for software-based omni-channel solutions. The analyst prefers NCR to Diebold and keeps Overweight ratings on both names.
07/12/17
FBCO
07/12/17
NO CHANGE
Target $26
FBCO
Outperform
Diebold upside could be 'substantial,' says Credit Suisse
Following the guidance reduction, Credit Suisse analyst Paul Condra believes the selloff was "a bit overdone" and expects the stock could regain some lost ground in the near-term. However, the move closer to $30 is likely to be mid to longer-term, he contends. Condra reiterates an Outperform rating and $26 price target on the shares.
NCR NCR Corp.
$36.60

0.05 (0.14%)

04/13/17
04/13/17
INITIATION

On The Fly: Top five analyst initiations
Catch up on today's top five analyst initiations with this list compiled by The Fly: 1. Auris Medical (EARS) initiated with a Buy at Roth Capital. 2. NCR Corp. (NCR) initiated with a Buy at Benchmark. 3. Guaranty Bancorp (GBNK) initiated with an Overweight at Piper Jaffray. 4. Six Flags (SIX) and SeaWorld (SEAS) were initiated with a Buy at SunTrust, while Cedar Fair (FUN) was initiated with a Hold. 5. Stericycle (SRCL) initiated with an Overweight at Barclays. This list is just a portion of The Fly's analyst coverage. To see The Fly's full Street Research coverage, click here.
04/21/17
BNCH
04/21/17
NO CHANGE
Target $55
BNCH
Buy
NCR Corp. pullback should be used as buying opportunity, says Benchmark
Benchmark analyst Daniel Kurnos said he was not surprised by the softness in ATM suggested in NCR Corp.'s Q1 report of the company's light Q2 guidance and he would use any pullback as a buying opportunity. The analyst, who thinks management is remaining conservative with guidance and that market tailwinds and new product rollouts should drive an acceleration in 2H17, keeps a Buy rating and $55 price target on NCR shares.

TODAY'S FREE FLY STORIES

SBUX

Starbucks

$57.43

(0.00%)

09:40
06/20/18
06/20
09:40
06/20/18
09:40
Technical Analysis
Technical Take: Starbucks extends post-update losses »

The stock is one of the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Jun

VWO

Vanguard FTSE Emerging Markets ETF

$43.19

(0.00%)

, EDU

New Oriental Education

$105.76

(0.00%)

09:40
06/20/18
06/20
09:40
06/20/18
09:40
Options
Unusually active option classes on open June 20th »

Unusual total active…

VWO

Vanguard FTSE Emerging Markets ETF

$43.19

(0.00%)

EDU

New Oriental Education

$105.76

(0.00%)

SBUX

Starbucks

$57.43

(0.00%)

DNR

Denbury Resources

$4.12

(0.00%)

WBA

Walgreens Boots Alliance

$64.61

(0.00%)

FDX

FedEx

$258.35

(0.00%)

IQ

iQIYI

$42.58

(0.00%)

GOOGL

Alphabet Class A

$1,178.29

(0.00%)

SPX

S&P 500

$0.00

(0.00%)

GE

General Electric

$12.96

(0.00%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Jun

  • 28

    Jun

  • 19

    Aug

  • 10

    Sep

  • 20

    Sep

  • 21

    Sep

SPWR

SunPower

$8.09

(0.00%)

09:40
06/20/18
06/20
09:40
06/20/18
09:40
Options
Rev/Con recap for Jun 19th »

Rev/Con recap for Jun…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

PCG

PG&E

$39.90

(0.00%)

09:39
06/20/18
06/20
09:39
06/20/18
09:39
Recommendations
PG&E analyst commentary  »

Morgan Stanley sees…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Jun

09:37
06/20/18
06/20
09:37
06/20/18
09:37
Conference/Events
House Financial Services Committee to hold a hearing »

The Terrorism &…

MKSI

MKS Instruments

$103.90

(0.00%)

, SSNLF

Samsung

$0.00

(0.00%)

09:36
06/20/18
06/20
09:36
06/20/18
09:36
Recommendations
MKS Instruments, Samsung analyst commentary  »

MKS Instruments offers…

MKSI

MKS Instruments

$103.90

(0.00%)

SSNLF

Samsung

$0.00

(0.00%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 10

    Sep

09:35
06/20/18
06/20
09:35
06/20/18
09:35
General news
U.S. existing home sales preview: »

U.S. existing home sales…

GE

General Electric

$12.96

(0.00%)

09:34
06/20/18
06/20
09:34
06/20/18
09:34
Recommendations
General Electric analyst commentary  »

GE's 'here to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

SBUX

Starbucks

$57.43

(0.00%)

09:34
06/20/18
06/20
09:34
06/20/18
09:34
Hot Stocks
Johnson says 'not immune' to geopolitical events, focused on long-term in China »

Starbucks CEO Kevin…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Jun

09:31
06/20/18
06/20
09:31
06/20/18
09:31
Conference/Events
House Financial Services Committee to hold a hearing »

The Committee holds a…

AMZN

Amazon.com

$1,735.74

(0.00%)

, JPM

JPMorgan

$107.58

(0.00%)

09:31
06/20/18
06/20
09:31
06/20/18
09:31
Hot Stocks
Amazon-Berkshire-JPMorgan healthcare joint venture names Atul Gawande CEO »

Amazon (AMZN), Berkshire…

AMZN

Amazon.com

$1,735.74

(0.00%)

JPM

JPMorgan

$107.58

(0.00%)

BRK.A

Berkshire Hathaway

$286,260.00

(0.00%)

BRK.B

Berkshire Hathaway

$190.38

(0.00%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Jun

  • 13

    Jul

  • 12

    Oct

ITRI

Itron

$58.50

(0.00%)

, SPKE

Spark Energy

$10.30

(0.00%)

09:31
06/20/18
06/20
09:31
06/20/18
09:31
Recommendations
Itron, Spark Energy analyst commentary  »

Itron added to Best Ideas…

ITRI

Itron

$58.50

(0.00%)

SPKE

Spark Energy

$10.30

(0.00%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

HOG

Harley-Davidson

$44.72

(0.00%)

09:31
06/20/18
06/20
09:31
06/20/18
09:31
Recommendations
Harley-Davidson analyst commentary  »

Harley-Davidson trends…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

09:30
06/20/18
06/20
09:30
06/20/18
09:30
General news
The U.S. current account gap widened »

The U.S. current account…

VHC

VirnetX

$3.45

(0.00%)

09:29
06/20/18
06/20
09:29
06/20/18
09:29
Hot Stocks
VirnetX enters reseller agreement with Above PAR Advisors »

VirnetX has entered into…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

PTCT

PTC Therapeutics

$33.21

(0.00%)

, SRPT

Sarepta

$143.92

(0.00%)

09:27
06/20/18
06/20
09:27
06/20/18
09:27
Recommendations
PTC Therapeutics, Sarepta analyst commentary  »

PTC Therapeutics weakness…

PTCT

PTC Therapeutics

$33.21

(0.00%)

SRPT

Sarepta

$143.92

(0.00%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Jun

  • 20

    Jun

AMZN

Amazon.com

$1,735.74

(0.00%)

, BRK.A

Berkshire Hathaway

$286,260.00

(0.00%)

09:25
06/20/18
06/20
09:25
06/20/18
09:25
Hot Stocks
Breaking Hot Stocks news story on Amazon.com, Berkshire Hathaway, Berkshire Hathaway, JPMorgan »

Amazon, Berkshire,…

AMZN

Amazon.com

$1,735.74

(0.00%)

BRK.A

Berkshire Hathaway

$286,260.00

(0.00%)

BRK.B

Berkshire Hathaway

$190.38

(0.00%)

JPM

JPMorgan

$107.58

(0.00%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Jun

  • 13

    Jul

  • 12

    Oct

TLGT

Teligent

$3.70

(0.00%)

09:25
06/20/18
06/20
09:25
06/20/18
09:25
Hot Stocks
Teligent announces FDA approval of Fluocinonide Gel, 0.05% »

Teligent announced it has…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

SPGI

S&P Global

$207.24

(0.00%)

, TST

TheStreet

$1.78

(0.00%)

09:25
06/20/18
06/20
09:25
06/20/18
09:25
Hot Stocks
S&P Global confirms purchase of RateWatch business from TheStreet »

S&P Global (SPGI)…

SPGI

S&P Global

$207.24

(0.00%)

TST

TheStreet

$1.78

(0.00%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

09:25
06/20/18
06/20
09:25
06/20/18
09:25
General news
FX Action: USD-CAD »

FX Action: USD-CAD topped…

AZZ

AZZ Inc.

$44.93

(0.00%)

09:25
06/20/18
06/20
09:25
06/20/18
09:25
Conference/Events
House Energy & Commerce Committee to hold a hearing »

The Energy Subcommittee…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

MTEX

Mannatech

$20.40

(0.00%)

09:24
06/20/18
06/20
09:24
06/20/18
09:24
Hot Stocks
Mannatech announces final results of modified Dutch auction tender offer »

Mannatech announced the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

FANG

Diamondback Energy

$127.56

(0.00%)

09:23
06/20/18
06/20
09:23
06/20/18
09:23
Recommendations
Diamondback Energy analyst commentary  »

Diamondback Energy…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

SBUX

Starbucks

$57.43

(0.00%)

09:23
06/20/18
06/20
09:23
06/20/18
09:23
Hot Stocks
Starbucks CEO says 'some canibalization,' new entrants hurt China SSS in Q3 »

Starbucks CEO Kevin…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Jun

EMCI

EMC Insurance

$27.28

(0.00%)

09:23
06/20/18
06/20
09:23
06/20/18
09:23
Upgrade
EMC Insurance rating change  »

EMC Insurance upgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.